Yes, the patterns of DNA methylation, including hypermethylation, can serve as biomarkers for cancer diagnosis, prognosis, and even treatment response. For instance, the detection of hypermethylated DNA in bodily fluids like blood, urine, or saliva can aid in the early detection of certain cancers. Additionally, changes in methylation patterns can provide insights into the likely progression of the disease and the patient's response to therapy.
